NEPH - Nephros, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
76.27M
Enterprise Value 3
70.22M
Trailing P/E
N/A
Forward P/E 1
-62.12
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
10.29
Price/Book (mrq)
2.10
Enterprise Value/Revenue 3
9.47
Enterprise Value/EBITDA 6
-21.88

Trading Information

Stock Price History

Beta (3Y Monthly) 1.99
52-Week Change 372.68%
S&P500 52-Week Change 37.98%
52 Week High 310.74
52 Week Low 33.69
50-Day Moving Average 37.87
200-Day Moving Average 36.09

Share Statistics

Avg Vol (3 month) 313.24k
Avg Vol (10 day) 355.1k
Shares Outstanding 57.67M
Float 2.99M
% Held by Insiders 111.93%
% Held by Institutions 147.06%
Shares Short (Sep 30, 2019) 426.97k
Short Ratio (Sep 30, 2019) 41.55
Short % of Float (Sep 30, 2019) 40.76%
Short % of Shares Outstanding (Sep 30, 2019) 40.35%
Shares Short (prior month Aug 30, 2019) 433.33k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 29/1
Last Split Date 3Jul 10, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -49.93%
Operating Margin (ttm)-45.79%

Management Effectiveness

Return on Assets (ttm)-22.50%
Return on Equity (ttm)-62.01%

Income Statement

Revenue (ttm)7.41M
Revenue Per Share (ttm)1.04
Quarterly Revenue Growth (yoy)69.00%
Gross Profit (ttm)3.2M
EBITDA -3.21M
Net Income Avi to Common (ttm)-3.7M
Diluted EPS (ttm)-0.52
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.32M
Total Cash Per Share (mrq)0.58
Total Debt (mrq)3.2M
Total Debt/Equity (mrq)47.02
Current Ratio (mrq)2.56
Book Value Per Share (mrq)4.74

Cash Flow Statement

Operating Cash Flow (ttm)-3.68M
Levered Free Cash Flow (ttm)-2.25M